TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL ADDICTION TREATMENT MARKET, BY TREATMENT TYPE
6.1. Overview
6.2. Alcohol Addiction Treatment
6.3. Tobacco/Nicotine Addiction Treatment
6.4. Opioid Addiction Treatment
6.5. Other Substances Addiction Treatment
7. GLOBAL ADDICTION TREATMENT MARKET, BY DRUG TYPE
7.1. Overview
7.2. Bupropion
7.3. Varenicline
7.4. Acamprosate
7.5. Disulfiram
7.6. Naltrexone
7.7. Methadone
7.8. Buprenorphine
7.9. Nicotine Replacement Products
7.10. Others
8. GLOBAL ADDICTION TREATMENT MARKET, BY TREATMENT CENTER
8.1. Overview
8.2. Outpatient Treatment Centers
8.3. Residential Treatment Centers
8.4. Inpatient Treatment Centers
9. GLOBAL ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL
9.1. Overview
9.2. Hospitals Pharmacies
9.3. Medical Stores
9.4. Others
10. GLOBAL ADDICTION TREATMENT MARKET, BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Addiction Treatment Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Addiction Treatment Market,
11.7. Key developments and Growth Strategies
11.7.1. New Product Launch/Service Distribution Channel
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. COMPANY PROFILES
12.1. Alkermes plc
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Cipla Ltd
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. GlaxoSmithKline plc
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Pfizer, Inc
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Mallinckrodt
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Hikma Pharmaceuticals PLC
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Orexo AB
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Titan Pharmaceuticals, Inc
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Teva Pharmaceutical Industries Ltd
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Products Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Indivor Plc
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Products Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL ADDICTION TREATMENT MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL ADDICTION TREATMENT MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 6 GLOBAL ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 11 US: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 12 US: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 13 US: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 14 US: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 15 CANADA: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 16 CANADA: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 17 CANADA: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 18 CANADA: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 19 EUROPE: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 20 EUROPE: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 21 EUROPE: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 22 EUROPE: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 23 GERMANY: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 24 GERMANY: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 25 GERMANY: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 26 GERMANY: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 27 FRANCE: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 28 FRANCE: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 29 FRANCE: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 30 FRANCE: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 31 ITALY: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 32 ITALY: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 33 ITALY: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 34 ITALY: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 35 SPAIN: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 36 SPAIN: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 37 SPAIN: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 38 SPAIN: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 39 UK: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 40 UK: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 41 UK: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 42 UK: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 43 REST OF EUROPE: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 44 REST OF EUROPE: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 45 REST OF EUROPE: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 46 REST OF EUROPE: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 47 ASIA-PACIFIC: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 48 ASIA-PACIFIC: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 49 ASIA-PACIFIC: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 50 ASIA-PACIFIC: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 51 JAPAN: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 52 JAPAN: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 53 JAPAN: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 54 JAPAN: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 55 CHINA: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 56 CHINA: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 57 CHINA: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 58 CHINA: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 59 INDIA: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 60 INDIA: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 61 INDIA: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 62 INDIA: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 63 AUSTRALIA: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 64 AUSTRALIA: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 65 AUSTRALIA: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 66 AUSTRALIA: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 67 SOUTH KOREA: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 68 SOUTH KOREA: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 69 SOUTH KOREA: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 70 SOUTH KOREA: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 71 REST OF ASIA-PACIFIC: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 72 REST OF ASIA-PACIFIC: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 73 REST OF ASIA-PACIFIC: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 74 REST OF ASIA-PACIFIC: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 75 REST OF THE WORLD: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 76 REST OF THE WORLD: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 77 REST OF THE WORLD: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 78 REST OF THE WORLD: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 79 MIDDLE EAST: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 80 MIDDLE EAST: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 81 MIDDLE EAST: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 82 MIDDLE EAST: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 83 AFRICA: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 84 AFRICA: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 85 AFRICA: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 86 AFRICA: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 87 LATIN AMERICA: ADDICTION TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 88 LATIN AMERICA: ADDICTION TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 89 LATIN AMERICA: ADDICTION TREATMENT MARKET, BY TREATMENT CENTER, 2018-2032 (USD BILLION)
TABLE 90 LATIN AMERICA: ADDICTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ADDICTION TREATMENT MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ADDICTION TREATMENT MARKET
FIGURE 4 GLOBAL ADDICTION TREATMENT MARKET, SHARE (%), BY TREATMENT TYPE, 2022
FIGURE 5 GLOBAL ADDICTION TREATMENT MARKET, SHARE (%), BY DRUG TYPE, 2022
FIGURE 6 GLOBAL ADDICTION TREATMENT MARKET, SHARE (%), BY TREATMENT CENTER, 2022
FIGURE 7 GLOBAL ADDICTION TREATMENT MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022
FIGURE 8 GLOBAL ADDICTION TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 NORTH AMERICA: ADDICTION TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 EUROPE: ADDICTION TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 ASIA-PACIFIC: ADDICTION TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 REST OF THE WORLD: ADDICTION TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 GLOBAL ADDICTION TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 14 ALKERMES PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 ALKERMES PLC: SWOT ANALYSIS
FIGURE 16 CIPLA LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 CIPLA LTD: SWOT ANALYSIS
FIGURE 18 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 GLAXOSMITHKLINE PLC: SWOT ANALYSIS
FIGURE 20 PFIZER, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 PFIZER, INC: SWOT ANALYSIS
FIGURE 22 MALLINCKRODT: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 MALLINCKRODT.: SWOT ANALYSIS
FIGURE 24 HIKMA PHARMACEUTICALS PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 HIKMA PHARMACEUTICALS PLC: SWOT ANALYSIS
FIGURE 26 OREXO AB: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 OREXO AB: SWOT ANALYSIS
FIGURE 28 TITAN PHARMACEUTICALS, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 TITAN PHARMACEUTICALS, INC: SWOT ANALYSIS
FIGURE 30 TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS
FIGURE 32 INDIVOR PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 INDIVOR PLC: SWOT ANALYSIS
